Shortage: Ifosfamide Injection
This page indexes a United States Food and Drug Administration (FDA) drug-shortage record for Ifosfamide Injection. The record is reported by Baxter Healthcare and currently carries a regulatory status of Current. A drug-shortage entry of this kind is an administrative supply-status record that the FDA maintains and publishes for transparency and reference. This entry names the affected product as Ifosfamide Injection, attributes the report to the company shown above, and records a status of Current marking where the shortage sits within the agency's public tracking lifecycle at the time it was ingested by this site. The affected presentation is described in the source as IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01). The availability field published by the FDA reads: Currently out of stock.. This shortage record was published on 2026-06-12. It was first posted on 2026-06-12. All values shown here are reproduced as regulatory data points from the official FDA drug-shortages dataset to help you find and verify the original entry. This page does not advise on therapeutic substitution, does not assess clinical impact, and is not a recommendation of any kind. Verify the current status against the linked FDA source.
Source-derived regulatory summary
The text in this section is generated from the FDA source fields shown elsewhere on this page. It is regulatory information only — not medical advice — and adds no facts beyond the official record.
This record pertains to Ifosfamide Injection, a product manufactured by Baxter Healthcare. It is presented as IFEX, available in a 3 g/60 mL injection format, with the National Drug Code (NDC) 0338-3993-01. The product is currently out of stock, with an estimated recovery date in October. The initial posting and last updated dates for this record are both June 12, 2026.
Regulatory context
The status of 'Current' indicates that this product is recognized and listed by the FDA, but its availability is currently affected by stock issues. The out-of-stock status does not imply any regulatory action but indicates a temporary supply issue.
Fields used include generic_name, status, presentation, availability, company_name, related_info, initial_posting_date, and last_updated_date. No fields were absent.
FDA shortage data
| Generic name | Ifosfamide Injection |
|---|---|
| Status | Current |
| Presentation | IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) |
| Availability (source text) | Currently out of stock. |
| Reporting company | Baxter Healthcare |
| Related information | Estimated recovery in October. |
| Initial posting date | 2026-06-12 |
| Last updated date | 2026-06-12 |
How to interpret this shortage record
A drug-shortage record means the FDA has logged a reported supply constraint for a product as part of its public shortage tracking. The status (Current) describes where the shortage sits in its lifecycle according to the agency's data. A shortage entry is an administrative supply signal — it does not describe the clinical role of the product, does not suggest any substitute, and does not indicate that any specific patient is affected. Read this entry as a pointer to the official FDA shortage listing and confirm the live status there before relying on it.
What this record does not mean
This shortage record does not constitute medical advice and does not tell you whether to start, stop, switch, or avoid any product. It does not assess safety for any individual, does not provide dosage, treatment, or therapeutic guidance, and does not diagnose any condition. The dataset is coverage-limited: it reflects what the FDA has published in the indexed source at ingestion time, which may lag the live record and may omit details held only in primary documents. For any health decision, consult a qualified healthcare professional, and for the authoritative record consult the FDA directly through the linked official source.
Related manufacturer
This shortage is reported by Baxter Healthcare. That page aggregates the firm's other indexed records as coverage-limited regulatory signals (not quality ratings).
Related shortages (Current)
- Ifosfamide Injection · 2026-06-12
- Ifosfamide Injection · 2026-06-12
- Ifosfamide Injection · 2026-06-12
- Ifosfamide Injection · 2026-06-12
- Ifosfamide Injection · 2026-06-12
Source & provenance
- Official source
- https://www.accessdata.fda.gov/scripts/drugshortages/
- Source dataset
- openFDA Drug Shortages API
- Publication date
- 2026-06-12
- Ingested
- 2026-06-14
- Record hash
1d427e395bfdd29e
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.